Disease | thrombocytosis |
Phenotype | C0007134|renal carcinoma |
Sentences | 1 |
PubMedID- 23864954 | Metastatic renal carcinoma patients with thrombocytosis (defined as platelets more than 400 × 109/l at least in one occasion during their disease) had a mean survival of 92 months compared with 151 months in patients with normal platelets [12]. |
Page: 1